Literature DB >> 16409157

Umbilical cord blood transplantation and banking.

Claudio G Brunstein1, John E Wagner.   

Abstract

Umbilical cord blood transplantation (UCBT) is an expanding practice for both pediatric and adult patients. Rapid availability, low risk of infectious disease transmission, lower risk of graft-versus-host disease, and lack of risk for the donor makes UCB an attractive alternative source of hematopoietic stem cells for transplantation. We review the state of the art of pediatric and adult UCBT and important aspects of UCB banking. Current strategies to improve clinical results and expand access to UCBT to a larger number of adult patients are discussed. New approaches to enhance hematopoietic recovery by the use of accessory cells or direct intra-bone marrow injection are also reviewed.

Entities:  

Mesh:

Year:  2006        PMID: 16409157     DOI: 10.1146/annurev.med.57.051804.123642

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  23 in total

1.  An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells.

Authors:  Hongmei Shen; Hui Yu; Paulina H Liang; Haizi Cheng; Richard XuFeng; Youzhong Yuan; Peng Zhang; Clayton A Smith; Tao Cheng
Journal:  Blood       Date:  2012-02-28       Impact factor: 22.113

2.  Stem cell biobanks.

Authors:  Silvana Bardelli
Journal:  J Cardiovasc Transl Res       Date:  2009-10-16       Impact factor: 4.132

3.  Umbilical cord blood banking options and the prenatal patient: an obstetrician's perspective.

Authors:  Jordan H Perlow
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

4.  In Vitro Differentiation and Expansion of Intrathymic T Cell Progenitors from Human Umbilical Cord Blood-Derived CD34(+) Cells.

Authors:  Bo Sun; Sang-Bum Park; Ji-Won Jung; Kwang-Won Seo; Yong-Soon Lee; Kyung-Sun Kang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

5.  Suppression of homeobox transcription factor VentX promotes expansion of human hematopoietic stem/multipotent progenitor cells.

Authors:  Hong Gao; Xiaoming Wu; Yan Sun; Shuanhu Zhou; Leslie E Silberstein; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

Review 6.  Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.

Authors:  Melhem Solh
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

7.  Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Daniel J Weisdorf; Todd DeFor; Juliet N Barker; Jakub Tolar; Jo-Anne H van Burik; John E Wagner
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

8.  Extensive haplotype diversity in African American mothers and their cord blood units.

Authors:  B Tu; N Leahy; R Yang; N Cha; K Kariyawasam; L Hou; Y Xiao; C Masaberg; D Pulse-Earle; M Maiers; J Ng; J Kurtzberg; C K Hurley
Journal:  Tissue Antigens       Date:  2012-11-20

9.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.

Authors:  Cheng Cheng Zhang; Megan Kaba; Satoru Iizuka; HoangDinh Huynh; Harvey F Lodish
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

10.  Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.

Authors:  J J Nietfeld; Marcelo C Pasquini; Brent R Logan; Frances Verter; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2008-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.